Dr Suchismitha Rajamanya As a child, most of us received a number of vaccines in order to prevent serious diseases. But did ...

The change was prompted by postmarketing observational studies that suggest an increased risk of GBS within 42 days of ...

The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and ...

At the 116,865 pre-travel visits, 25% of travelers were eligible to receive the pneumococcal vaccine, but only 68% of the ...

Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC continued to monitor for GBS risk. FDA conducted a postmarket ...